XML 93 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Quarterly Financial Data
12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data
Quarterly Financial Data (unaudited)
(In millions, except per share data)
 
Thirteen Weeks Ended
 
March 29,
2014
 
June 28,
2014
 
September 27,
2014
 
December 31,
2014
Net sales
$
4,359.8

 
$
4,585.1

 
$
4,232.7

 
$
4,549.7

Gross profit
360.5

 
379.1

 
361.2

 
392.0

Consolidated net income
128.6

 
157.8

 
147.9

 
268.0

Net income attributable to Lear
122.0

 
148.5

 
140.1

 
261.8

Basic net income per share attributable to Lear
1.50

 
1.84

 
1.75

 
3.32

Diluted net income per share attributable to Lear
1.47

 
1.81

 
1.72

 
3.24


In the first quarter of 2014, the Company recognized losses of $17.5 million related to the redemption of the remaining outstanding aggregate principal amount of the 2018 Notes and 10% of the original aggregate principal amount of the 2020 Notes. In the first, second, third and fourth quarters of 2014, the Company recognized $15.4 million, $17.9 million, $6.9 million and $108.9 million of net tax benefits, respectively, primarily related to net reductions in valuation allowances with respect to the deferred tax assets of certain foreign subsidiaries, reductions in tax reserves due to audit settlements, debt redemption costs, restructuring charges and various other items.
 
Thirteen Weeks Ended
 
March 30,
2013
 
June 29,
2013
 
September 28,
2013
 
December 31,
2013
Net sales
$
3,947.1

 
$
4,113.1

 
$
3,917.7

 
$
4,256.1

Gross profit
312.4

 
337.7

 
330.2

 
319.4

Consolidated net income
116.9

 
142.3

 
116.7

 
79.9

Net income attributable to Lear
108.5

 
137.3

 
112.8

 
72.8

Basic net income per share attributable to Lear
1.14

 
1.62

 
1.40

 
0.90

Diluted net income per share attributable to Lear
1.13

 
1.60

 
1.38

 
0.88


In the second and fourth quarters of 2013, the Company recognized $21.5 million of net tax benefits and $16.0 million of net tax expense, respectively, primarily related to changes in valuation allowances with respect to its deferred tax assets in certain foreign subsidiaries and various other items.
For further information, see Note 7, "Income Taxes," and Note 11, "Commitments and Contingencies," to the consolidated financial statements included in this Report.